HighRad

HighRAD is an Israeli healthtech company that provides an FDA-cleared AI imaging platform designed to revolutionize oncology care through advanced longitudinal analysis. The company's proprietary Region of Difference (ROD) technology and SimU-Net deep learning algorithms enable the automated detection, segmentation, and measurement of lesions across multiple organs using CT, MRI, and PET scans. By providing quantitative and comparative data, HighRAD helps radiologists and oncologists track disease progression and evaluate treatment efficacy with greater precision and efficiency. The platform is also utilized by pharmaceutical research teams to gain deeper insights into drug responses during clinical studies. HighRAD's solutions integrate seamlessly into existing clinical workflows and adhere to standardized reporting guidelines such as RECIST 1.1.